Netcracker and Swisscom Win TM Forum Excellence Award for Pioneering Autonomous Operations Program
With Netcracker as its strategic partner, Swisscom set out on an ambitious transformation program encompassing network and IT that would simplify its path to autonomous networking across the company. The approach was based on the decomposition of its OSS into many smaller autonomous operational domains based on the TM Forum ODA framework.
Using Netcracker's Domain Automation solution, IP Transport was the first domain to be fully modernized and automated, incorporating advanced intent-based Service Orchestration, real-time Resource Inventory and AI/ML. The cloud-native solution brought numerous benefits to Swisscom, including shorter time to market, increased service stability, cost reductions and improved efficiencies.
Swisscom and Netcracker further innovated with the creation of a domain automation blueprint to maximize tool sharing, best practices and standards across all domains. In addition, offering IT-as-a-Service allows domain teams to rapidly modernize and deploy additional domains to deliver efficient replication and scale across the organization.
'We've worked closely with Netcracker for years, and our bold transformation approach and proven success with the IP Transport domain is creating the path for autonomous networking company wide,' said Rudolf Strijkers, Enterprise and Security Architect at Swisscom. 'With modular architecture and IT-as-a-Service, we're accelerating domain and cross-domain automation to bring agility and efficiency across our business. We could not be more gratified to receive this very prestigious award as validation of our joint work with our partner Netcracker.'
'The judges were very impressed with the significant improvements in service rollout, cost savings and advanced automation,' said Joann O'Brien, VP, Digital Ecosystems at TM Forum. 'We congratulate Netcracker and Swisscom on this groundbreaking project.'
'Netcracker is proud to be part of Swisscom's pioneering work to modernize and automate its network through such an ambitious transformation,' said Ari Banerjee Chief Strategy Officer at Netcracker. 'Our deep collaboration together with our intelligent automation solutions are helping Swisscom achieve operational excellence that will help them stay at the forefront of innovation.'
About Netcracker Technology
Netcracker Technology, a wholly-owned subsidiary of NEC Corporation, has the expertise, culture and resources to help service providers around the world transform their businesses to thrive in the digital economy. Our innovative solutions, value-driven services and unbroken delivery track record have enabled our customers to grow and succeed for more than three decades. With the latest technological advancements in key areas including 5G monetization, AI, automation and vertical industries, we help service providers to reach their transformation goals, advance their telco to techco evolution and realize business growth and profitability. To learn more, visit www.netcracker.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Benchmark Announces Appointment of Chuck Swoboda to Board of Directors
TEMPE, Ariz., August 04, 2025--(BUSINESS WIRE)--Benchmark Electronics, Inc. (NYSE: BHE), a global provider of engineering, design, and manufacturing services, today announced the appointment of Charles "Chuck" Swoboda to its Board of Directors. Mr. Swoboda brings over three decades of leadership in technology, innovation, and manufacturing experience to Benchmark's Board. He is the former Chairman and CEO of Cree, Inc., where he led the transformation of the company from a $177 million R&D-focused business into a $1.6 billion global leader in semiconductors and LED lighting. During his tenure, he championed a culture of innovation, launched thousands of new products, and helped secure over 5,000 patents, including 24 as a co-inventor. "Chuck is a visionary leader whose track record in scaling advanced technology businesses and driving innovation aligns perfectly with Benchmark's strategic direction," said Jeff Benck, President and CEO of Benchmark. "Chuck's experience in semiconductors, IoT, and global operations will be invaluable as we continue to expand our complex solution capabilities and deliver further value to our customers." "Chuck's deep understanding of advanced manufacturing, operational excellence, and global supply chains will enhance our board's perspective," said David W. Scheible, Chairman of the Board. "We are excited to welcome him and look forward to his contributions." In addition to his role at Cree, Mr. Swoboda currently serves on the board of Ryder System, Inc. (NYSE: R) and has held board positions at Anixter International, Vesper Technologies, and several early-stage technology companies. He is also the author of The Innovator's Spirit and serves as Innovator-in-Residence at Marquette University. Mr. Swoboda holds a Bachelor of Science in Electrical Engineering from Marquette University. To learn more about Benchmark's Board of Directors, please visit About Benchmark Electronics, Inc. Benchmark provides comprehensive solutions across the entire product lifecycle; leading through its innovative technology and engineering design services; leveraging its optimized global supply chain; and delivering world-class manufacturing services in the following industries: aerospace and defense, advanced computing and communications, industrial, medical, and semiconductor capital equipment. Benchmark's global operations include facilities in seven countries and its common shares trade on the New York Stock Exchange under the symbol BHE. View source version on Contacts Paul ManskySr. Director of Investor Relations and Corporate DevelopmentEmail: Phone: 623-300-7052 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
5 hours ago
- Forbes
20 Ways Executives Ignore Leadership Challenges—And Why It's Risky
getty From hybrid schedules and technology shifts to growing employee concerns around purpose, trust and well-being, workplace expectations are changing in myriad ways that directly affect how leaders operate. In response, some executive leaders are staying heads-down, focused on day-to-day demands, short-term priorities and putting out fires. While it might seem prudent, that kind of reactive focus can come at a cost: Deeper issues may go unnoticed until they've already impacted performance, retention or long-term growth. Here, 20 Forbes Coaches Council members share challenges that many leaders are struggling to address right now, along with the risks of ignoring them and leaving these issues unresolved. 1. Focusing Only On What's Happening Now Uncertainty paralyzes innovation. Many leaders are waiting for stability to pursue growth, risking stagnation. But shifting from 'What's happening now?' to 'What's possible next?' empowers leaders to rally their teams, envision multiple futures and begin preparing for what could be. It's not predicting the future; it's creating the capacity to meet it confidently. - Lisa L. Baker, Ascentim 2. Rushing To Invest; Overlooking Existing Resources Leadership ignores the pause and thinks holistically. With FOMO driving them to 'keep up,' companies keep investing more in the tech stack for new services, totally ignoring the optimization of the investment already made. At times, services already exist but go unused, and leaders are unaware. It goes against both an organization's environment and its financials. - Nav Thethi, The Nav Thethi 3. Ignoring A Growing Lack Of Employee Trust There is a growing lack of trust in their leaders among employees. Layoffs, the dismantling of DEI efforts, return-to-office mandates and smaller (or no) pay increases or bonuses are all contributing to employees' lack of trust. As leaders, we need to be aware of our employees' concerns, address them openly and honestly, and show the integrity our employees need to see. - John Cleveland Forbes Coaches Council is an invitation-only community for leading business and career coaches. Do I qualify? 4. Failing To Focus On Adaptability And Agility Leaders today are struggling to focus on adaptability: navigating change with clarity and agility. Ignoring this risk erodes resilience, delays decisions and weakens competitive edge. In today's fast-changing environment, adaptability is not a soft skill; it's the core of sustainable leadership. - Mehmet Egilmezer, International Coaching Education Group LLC 5. Treating AI Like A Buzzword; Not Focusing On Use Cases There's too much focus on AI as a buzzword, but not enough focus on real use cases that generate tangible results. You can't ignore this discussion either, as someone will get it right, and it could be your competition. Build momentum with one to three solid use cases and work them to success. Take the learnings to build other use cases. One positive side effect is the employee engagement built in the process. - Curtis L. Jenkins, Jenkins & Associates 6. Losing Engagement With Virtual Audiences Five years ago, the business world discovered it had to do business on Zoom, Teams and other platforms. Even five years later, so many leaders are bad at video presence. That means that people in meetings zone out, misunderstand or don't appreciate priorities. Hybrid meetings are worse. So a key leadership challenge is to keep virtual audiences engaged. That takes effort, energy and intentionality. - Helio Fred Garcia, Logos Consulting Group 7. Neglecting Personal Branding And Influence Focusing on their communication skills, building their personal brand and having a consistent influence are challenges for today's business leaders. The risks: Their messages are misunderstood, which impacts productivity, employee morale and profits. They risk jeopardizing their personal brand, damaging their trust, confidence, impact and credibility. They damage their relationships and influence their top performers to leave. - Stacey Hanke, Stacey Hanke Inc. 8. Not Helping People Live Their Purpose One big issue is that people want to live their purpose, and organizations don't get what that means, nor do they realize the risks of ignoring it—unfulfilled employees mean an impact on profit and overall success. A simple focus by leadership on listening, paying attention and pointing people to where they are already interested will remind them of their passion and will give them energy for their work. Try it! - Darla Beam, Darla Beam Leadership & Coaching 9. Being Busy To The Point Of Saturation (And Dilution) Leaders today are not just busy—they're saturated. Saturation leads to dilution: of clarity, of presence and of power. And when leaders are diluted, so is their impact. But most don't realize it because they're still producing. They are still performing—which is exactly why it's so dangerous. The risk isn't just burnout. It's misdirected energy, frustration, stagnation, poor decisions and loss of talent. - Gia Lacqua, Gia Lacqua 10. Struggling To Adapt To A Faster Pace Of Business The rapid pace of business today is consistently working against the plans of leadership. The persistent dilemma of choosing to sprint versus going at it like a marathon is a real issue for organizations. Technology and consumer demands have significantly raised the bar for turnaround times, and leadership has had to adapt to quicker execution plans to meet new expectations and standards. - Stefanie Ricchio, SRBC Inc. 11. Reacting Instead Of Leading Leaders are struggling to slow down long enough to think. In Navy SEAL training, they say go slow to go fast. But in today's urgency culture, leaders skip reflection and taking the time to zoom out—and end up reacting instead of leading. The risk? Burnout, poor decisions and teams running hard in the wrong direction. Slowing down isn't a luxury—it's a leadership discipline. - Jodie Charlop, Exceleration Partners 12. Prioritizing Short-Term Results; Losing Talent The constant pressure for short-term results is contributing to widespread burnout and declining employee engagement. Leaders often overlook the true cost of turnover, which can exceed 150% of an employee's salary. The hidden risk is that valuable organizational knowledge and culture built over years quietly disappear as experienced talent exits. - Christine Daniels, Christine Daniels LLC 13. Poorly Communicating With Different Personalities Being able to communicate effectively with team members who have different personalities is a challenge. Not everyone thinks or communicates as you do as a leader. Build your skill set of recognizing the communication styles of your team members and pivoting to meet their emotional needs. Identify their unique traits and focus on getting them to reach their full potential, as it's not a paint-by-numbers process. - Bryan Powell, Executive Coaching Space 14. Not Prioritizing Leadership Development Many CEOs are struggling to prioritize leadership team development amid deal delays and mounting pressure from investors. Ignoring it risks poor performance, failed exits and lost value. Investors expect CEOs to navigate what's next, not just survive it. In uncertain markets, leadership versatility isn't optional—it's the lever that drives alignment, resilience and returns. - Dan Hawkins, Summit Leadership Partners 15. Fostering Insufficient Psychological Safety One major challenge business leaders face is creating psychological safety in fast-paced, high-pressure environments. If ignored, team members may withhold ideas, avoid taking risks and disengage, leading to poor collaboration, less innovation and weakened team performance. To overcome this, start by listening actively and making it safe for people to speak up without fear of judgment. - Weixi Tan, Workplace Asia 16. Ignoring Employee Well-Being A big issue that is often ignored is employee well-being. How people feel about themselves, their workplace, work itself and the people they work with plays a crucial role in their engagement, performance and loyalty. At the same time, this is also true for those in leadership positions. Unfortunately, it is still seen as a 'soft' factor many times, leading to burnout and (quiet) quitting. - Thomas Gelmi, Movadis AG 17. Neglecting To Meaningfully Connect With Teams One issue that leaders are finding it hard to focus on is making meaningful time with their leadership and downstream teams to focus on the 'why' and to connect the priorities back to the vision. One-on-ones are cancelled, there is low attendance at leadership sessions, and the 'busy' factor is keeping leaders from understanding what and how their teams are operating and where gaps need to be addressed. - Laurie Waligurski, LGW Executive Consultants, LLC 18. Overlooking A Cognitive Bandwidth Shortage Most leaders are ignoring cognitive bandwidth. In a world of overwhelm, attention is the new oil. Miss this, and you burn out teams, bury innovation and bleed momentum. Train your focus like a muscle. Otherwise, distraction becomes your culture. - Adam Levine, InnerXLab 19. Allowing Hybrid Disengagement To Deepen Hybrid work disengagement erodes morale and productivity. Leaders must combat this by prioritizing empathy, crystal-clear communication and inclusive strategies to keep teams aligned and motivated in this new work reality. Failure risks a significant performance decline. - Maryam Daryabegi, Innovation Bazar 20. Not Developing Structured Remote Training One of the issues leaders face today is the lack of structured training for early-career employees. The bottom rung of the ladder is often broken, especially in hybrid workplaces, where new hires may miss out on shadowing and real-time learning opportunities. Without clear in-person and remote training for all employees, we continue to burn through talent who don't see a path forward. - Jill D. Griffin, The Griffin Method
Yahoo
5 hours ago
- Yahoo
Organ Care Products Market Valuation Set to Surpass US$ 812.12 Million By 2033
Innovation now defines the organ care products market. Advanced perfusion and portable systems are actively expanding the donor organ pool, tackling immense waiting lists driven by chronic diseases and dramatically improving success rates for vital transplants. Chicago, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The global organ care products market was valued at US$ 199.20 million in 2024 and is expected to reach US$ 812.12 million by 2033, growing at a CAGR of 16.90% during the forecast period 2025–2033. The current scenario in the organ care products market is one of explosive growth, fueled by the twin engines of unprecedented global demand and transformative technology. In 2024, the U.S. performed a record 48,149 transplants, yet this barely meets the need, as regions like Eurotransplant still have over 13,570 patients on waiting lists. This profound supply-demand imbalance is accelerating a fundamental shift away from traditional static cold storage towards advanced perfusion and assessment systems. These technologies are directly addressing the critical issue of organ non-utilization, aiming to convert a portion of the thousands of organs discarded annually into life-saving opportunities, thereby changing the entire calculus of transplantation. Request Sample Pages: This evolution is being aggressively capitalized upon by key industry players through strategic expansion and is buoyed by substantial investment. Recent developments, such as Paragonix's EU MDR certification for five devices in March 2025 and its rapid U.S. commercial expansion, highlight a fierce race to capture market share. The market's momentum is further underwritten by significant capital influx, from government initiatives like the $67 million allocated for U.S. transplant system modernization in FY2025 to targeted research funding from organizations like Enduring Hearts. The current scenario is therefore not just about growth, but about a well-funded, strategic push to commercialize innovation on a global scale. Key Findings in Organ Care Products Market Market Forecast (2033) US$ 812.12 million CAGR 16.90% Largest Region (2024) North America (56%) By Organ Type Kidney (28%) By Product Type Trolly (53%) Top Drivers Rising global incidence of chronic diseases fuels organ transplant demand. Technological advancements in organ preservation systems improve transplant success rates. Favorable reimbursement policies encourage organ transplant procedures, boosting market growth. Top Trends Emergence of normothermic machine perfusion for real-time organ function assessment. Development of smaller, portable organ preservation devices for easier transport. Focus on developing organ-specific preservation solutions for better patient outcomes. Top Challenges Complex ethical and logistical hurdles in organ procurement and allocation. Unprecedented Transplant Volumes Are Fueling Robust Market Expansion and Demand The foundational driver for the organ care products market is the sheer volume of surgical procedures, which continued its upward trajectory through 2024. In the United States alone, a record of over 48,000 organ transplants were performed. This milestone was confirmed with a final tally of 48,149 procedures for the year, marking the first time the nation has exceeded this figure. This represents an impressive average of 132 organ transplants performed each day in the U.S. throughout 2024. Critically, 2024 marked the 14th consecutive year of growth in the number of organs recovered for transplants in the U.S., signaling a sustained and reliable increase in the core activity that underpins the market. This trend is not isolated; globally, organ transplantation activities saw a notable increase in 2023, which has set a strong precedent for continued growth in 2024 and beyond. In Europe, the eight Eurotransplant countries allocated 7,150 organs from deceased donors in 2024, while in China, a remarkable 24,684 transplant surgeries were performed during the same year, showcasing the truly global nature of this expansion. The Critical Role of Organ Procurement in Shaping Market Dynamics The availability and procurement of donor organs represent the starting point for the entire transplantation value chain, directly influencing the organ care products market. In the United States, 55 dedicated organ procurement organizations (OPOs) were operational as of October 2024, forming the backbone of the recovery network. In 2024, these U.S. OPOs successfully recovered over 45,000 organs for transplant procedures. This was made possible by the 16,989 Americans who became deceased organ donors, a testament to growing awareness and consent. These efforts were supplemented by more than 7,000 living donors in the U.S. in 2024. An interesting demographic trend shows that nearly 8,200 of the deceased donors in the U.S. in 2024 were aged 55 and older, highlighting the expanding criteria for donation. In the United Kingdom, from April 2023 to March 2024, there were 1,510 deceased organ donors and 938 living organ donors. Across the Eurotransplant region, organs were sourced from 2,181 deceased donors in 2024. Meanwhile, China recorded 6,744 cases of organ donations in 2024, with the number of registered organ donors soaring to over 7.05 million by early 2025, indicating massive future potential. Organ-Specific Procedural Growth Creates Niche Opportunities Within the Market A deeper analysis of procedural data reveals that growth is not uniform across all organ types, creating distinct and lucrative opportunities within the organ care products market for specialized preservation technologies. In the United States during 2024, cardiac procedures were significant, with 4,572 heart transplants performed. Thoracic procedures were also prominent, as the number of lung transplants reached 3,340. Abdominal transplants, which constitute the largest segment, saw a total of 11,458 liver transplants and an impressive 27,759 kidney transplants performed in the U.S. in 2024. This high volume in renal transplantation underscores the demand for reliable kidney preservation solutions. Furthermore, specialized procedures are gaining traction; in the UK, for instance, 65 Donation after Circulatory Death (DCD) heart transplants took place in the 2023/24 period, a complex procedure that relies heavily on advanced preservation technology to ensure viability. Diverse Regional Landscapes Present Unique Challenges and Growth Avenues The global organ care products market is characterized by significant regional variations in infrastructure, regulatory frameworks, and donation patterns. China's market, for example, is notable for its scale; as of early 2025, there have been more than 58,000 cumulative organ donations to date. The country has also recorded over 63,000 body donations and 110,000 corneal donations as of 2025, pointing to a well-established and growing donation culture. In the UK, the data from 2023-2024 provides a detailed look at the procurement funnel, with 772 donors after brain death (DBD) and 738 donors after circulatory death (DCD). That year, there were 6,794 potential deceased organ donors identified in the UK, of whom 6,421 were formally referred as potential donors. From that pool, donation requests were made to families in 3,107 cases, ultimately resulting in 1,880 consented donors, illustrating the multi-step process where advanced care technology can play a role in boosting confidence and consent. Groundbreaking Product Innovation and Regulatory Wins Propel Market Leaders Forward Innovation is the lifeblood of the organ care products market, with regulatory approvals serving as key milestones that unlock new commercial opportunities. In October 2024, Paragonix Technologies achieved a major milestone with FDA 510(k) clearance for its KidneyVault portable renal perfusion system. This strategic clearance solidified Paragonix as the only company possessing U.S. regulatory clearances for advanced preservation devices for all five solid organs used in transplants. Earlier in the year, in June 2024, the company launched its PancreasPak, the world's first FDA-cleared preservation device for donor pancreases, with pre-orders beginning on June 27, 2024, and full commercial availability planned for September 1, 2024. In April 2024, Paragonix also announced the full U.S. commercial launch of its BAROguard Donor Lung Preservation System. During its limited market release, 5 of the top U.S. thoracic transplant centers had already deployed the BAROguard System. The momentum continued into 2025, when Paragonix received EU MDR approval for five of its organ preservation devices in March. These specific product approvals stood out in a year where the FDA approved a total of just 21 medical devices overall in 2024. Strong Financial Performance and Strategic Investments Signal a Healthy Marketplace The financial health and strategic initiatives of key industry players in the organ care products market provide compelling evidence of a vibrant and growing market. XVIVO Perfusion reported strong results for 2024, with net sales amounting to SEK 822.4 million for the full year. The fourth quarter of 2024 was particularly robust, with net sales reaching SEK 227.6 million. The company's profitability was also solid, with an operating income (EBIT) for Q4 2024 of SEK 15.5 million and an operating income before depreciation and amortization (EBITDA) of SEK 51.9 million. Strong operational execution led to a cash flow from operating activities of SEK 62.1 million in Q4 2024, and the company posted a net profit for the full year 2024 of SEK 172.2 million. On the utilization front, Paragonix preservation devices have been used in over 10,000 transplant cases globally as of March 2025, demonstrating deep market penetration. Specifically, the Paragonix SherpaPak and LUNGguard systems are utilized at over 150 transplant centers globally, including over 40 transplant centers in the EU, highlighting the company's expanding international footprint. Modernization Initiatives and Research Funding Pave the Way for Future Growth Substantial government and institutional investments in research and system modernization are creating a fertile ground for the future growth of the organ care products market. The U.S. Senate Appropriations Committee has included a significant $67 million in funding for the Organ Procurement and Transplantation Network (OPTN) Modernization Initiative for fiscal year 2025. This represents a $13 million increase over FY 2024 levels. The FY24 funding package had already included an additional $23 Million for the HRSA OPTN Modernization Initiative, bringing the total for that year to $52 Million. In 2024, the Mid-America Transplant Foundation's Clinical Innovation Fund began offering awards of up to $150,000 per year for three years to spur new research. The American Society of Transplantation (AST) is furthering this by offering a research grant of $75,000 for one year, with a term starting January 1, 2025. The International Society for Heart & Lung Transplantation is offering a grant of up to $75,000 for research into DCD heart transplantation, with recipients to be announced in January 2025, and a second grant of up to $37,500 for acellular Ex Vivo Lung Perfusion (EVLP) research. In 2024, the Scandiatransplant Research grant also supported two projects with 100,630 DKK and 260,000 DKK, respectively. Need a Customized Version? Request It Now: Addressing Organ Utilization and Waiting Lists Remains a Core Market Imperative The persistent challenges of organ non-utilization and extensive patient waiting lists serve as powerful catalysts for the organ care products market, driving the need for technologies that can preserve, assess, and improve marginal organs. In 2024, a concerning 9,275 recovered kidneys in the U.S. were ultimately not used for transplant, continuing a trend that highlights a critical gap between recovery and utilization. To combat this, OPOs have hosted eleven Transplant Growth Collaborations over the past year to share successful practices. Advanced perfusion is emerging as a key solution; a 2024 study of 803 transplantations, of which 174 received Normothermic Machine Perfusion (NMP), showed NMP was associated with a reduced need for early relaparotomy in liver transplants. Another 2024 study involving 118 NMP-treated livers matched with 236 preserved with static cold storage, and a cohort matching 37 NMP-DCD livers with 74 using static cold storage, are providing crucial data on efficacy. Global Organ Care Products Market Major Players: Bridge to Life Ltd. TransMedics Inc. Organ Recovery system XVIVO Preservation Solution Inc. Paragonix technologies and IGL OrganOx Limited Other Prominent Players Key Market Segmentation: By Organ Type Kidney Liver Heart Lungs Others By Product Type Trolly Portable By Region North America Europe Asia Pacific Middle East Africa South America Request a Personalized Report Walkthrough with Our Research Team: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
